Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL B22GK 2 2 5 IN PLASTIC CONTAINER versus PRISMASOL B22GK 4 0 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL B22GK 2 2 5 IN PLASTIC CONTAINER versus PRISMASOL B22GK 4 0 IN PLASTIC CONTAINER.
PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER vs PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol B22GK is a sterile hemodialysis solution containing electrolytes and buffer (lactate or bicarbonate). It corrects electrolyte imbalances, acid-base disturbances, and removes uremic toxins by diffusion and convection across a semipermeable membrane during continuous renal replacement therapy (CRRT).
Prismasol B22GK 4/0 is a sterile, bicarbonate-based hemofiltration solution used in continuous renal replacement therapy (CRRT). It replaces electrolytes and buffers in the blood, correcting metabolic acidosis and removing waste products via convection and diffusion. The solution contains bicarbonate as a buffer to maintain acid-base balance.
Not applicable; PRISMASOL B22GK is a hemodialysis/hemofiltration solution used for continuous renal replacement therapy (CRRT) at flow rates of 1000-3000 mL/h according to patient needs and machine settings.
Continuous renal replacement therapy (CRRT): 1.5-2.0 L/h effluent rate, typically administered as continuous venovenous hemofiltration (CVVH) or hemodiafiltration (CVVHDF). Route: intravenous via CRRT circuit. Frequency: continuous infusion.
None Documented
None Documented
Not applicable; continuous infusion with rapid renal elimination. For lactate, endogenous half-life ~5-10 minutes under normal conditions.
Not applicable as a drug; the half-life of infused bicarbonate/lactate in patients is approximately 5–10 minutes for lactate conversion and bicarbonate distribution, but this is not relevant to the solution itself.
Renal: 100% (mainly as bicarbonate and other buffer components; not metabolized). Biliary/fecal: negligible.
Prismasol B22GK 4/0 is a dialysis solution containing electrolytes and buffer (bicarbonate/lactate). It is not systemically absorbed; during continuous renal replacement therapy (CRRT), solutes and fluid are removed via hemofiltration/dialysis. The solution components are eliminated by the dialysis membrane and not subject to systemic excretion.
Category C
Category C
Dialysis Solution
Dialysis Solution